Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of MR902 vs IR Morphine in Healthy Subjects
NCT02773316Phase 1Completed
- Sponsor
- Mundipharma
- Start
- Sep 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of morphine sulfate in pain (2 cohorts), sponsored by Mundipharma. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve to time t. Started Sep 2015; status: completed.
02
Drugs
morphine sulfate
03
Conditions
pain
Beyond the preview
Go deeper on NCT02773316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02773316.